Metrikler
Yayın
217
Açık Erişim
7
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1990 - 1992
1990 - 1992Tıpta Yandal Uzmanlık
İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
Akademi Dışı Deneyim
1993 - Devam Ediyor
1993 - Devam EdiyorÖğretim Üyesi
İ.Ü.İstanbul Tıp Fakültesi, Öğretim Üyesi
Makaleler
Tümü (159)
SCI-E, SSCI, AHCI (124)
SCI-E, SSCI, AHCI, ESCI (143)
ESCI (17)
Scopus (143)
TRDizin (34)
Diğer Yayınlar (9)
2025
20251. A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease
İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., İmanov Z., et al.
Scientific Reports
, cilt.15, sa.1, 2025 (SCI-Expanded)
2025
20252. Extra intestinal manifestations may increase the risk of synchronous and metachronous development of other extraintestinal manifestations in patients with Crohn’s disease
Ozkahraman A., Kayar Y., Dertli R., Konur S., Kılıc G., Baran B., et al.
Scientific Reports
, cilt.15, sa.1, 2025 (SCI-Expanded)
2025
20253. Letter on “Long-Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver-Related Events in Nucleos(t)ide Analogue-Treated Chronic Hepatitis B Patients in China”
Bilgin E., Çavuş B., Kaymakoğlu S.
Alimentary Pharmacology and Therapeutics
, cilt.62, sa.9, ss.959-960, 2025 (SCI-Expanded)
2025
20254. Real World Efficacy and Safety of Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Liver Transplant Recipients
Bektas E., Yilmaz A., Kikili C. I., Nuriyev K., Istemihan Z., Senkal I. V., et al.
Transplant Infectious Disease
, cilt.27, sa.5, 2025 (SCI-Expanded)
2025
20255. USTEKINUMAB EFFECTIVENESS AND SUSTAINABILITY IN ULCERATIVE COLITIS AND CROHN’S DISEASE
İstemihan Z., Teberik Kama E., Altın S., İmanov Z., Şenkal İ. V., Nurıyev K., et al.
Journal of İstanbul Faculty of Medicine , sa.88, ss.256-263, 2025 (Hakemli Dergi)
2025
20256. The role of GALAD score in the surveillance of hepatocellular carcinoma.
İstemihan Z., Şenkal İ. V., Karaca D., Nurıyev K., Rustamzade A., Genç Uluçeçen S., et al.
Scientific reports
, cilt.15, sa.1, ss.22279, 2025 (SCI-Expanded)
2025
20257. The Role of Pancreatic Enzyme Insufficiency in the Etiology of Functional Dyspepsia Resistant to Standard Treatment
kemik f., CEYLAN G., Aydın A. F., Çavuş B., Ormeci A., Imanov Z., et al.
Turkish Journal of Gastroenterology
, cilt.36, sa.7, ss.467-473, 2025 (SCI-Expanded)
2025
20258. Results in chronic hepatitis B patients using tenofovir and entecavir for at least 10 years; HBV clearance rare, disease outcomes good: An observational cohort study
Istemihan Z., Kemeç G., Cebeci T., Çetin O., Uluçeçen S. G., Rüstemzade A., et al.
Medicine (United States)
, cilt.104, sa.23, 2025 (SCI-Expanded)
2025
20259. Large Scale MRI Collection and Segmentation of Cirrhotic Liver
Jha D., Susladkar O. K., Gorade V., Keles E., Antalek M., Seyithanoglu D., et al.
SCIENTIFIC DATA
, sa.1, 2025 (SCI-Expanded)
2025
202510. The Role of MicroRNA-192-5p in the Pathogenesis of Crohn's Disease
Dicle E. O., Ulucecen S. G., İSTEMİHAN Z., ÇAVUŞ B., OĞUZ F., KAYMAKOĞLU S., et al.
HLA
, cilt.105, 2025 (SCI-Expanded)
2025
202511. Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study
Dirim M. G., Ormeci A. C., Cavus B., Poyanli A., Serin K. R., Akyuz F., et al.
Turkish Journal of Gastroenterology
, cilt.36, sa.4, ss.219-228, 2025 (SCI-Expanded)
2025
202512. Hepatopulmoner Sendrom
İstemihan Z., Kaymakoğlu S.
Türkiye Klinikleri Gastroenterohepatoloji Dergisi , cilt.18, ss.47-52, 2025 (Hakemli Dergi)
2025
202513. The impact of cART on hepatic steatosis and fibrosis in treatment-naïve PLwHIV: A prospective cohort study
Sahin Ozdemir M., Ozdemir Y. E., Dogdas A., NURIYEV K., ŞENKAL İ. V., Gunduz A., et al.
International Journal of STD and AIDS
, 2025 (SCI-Expanded, Scopus)
2025
202514. Virological and Biochemical Effects of Tenofovir Alafenamide in Different Patient Groups With Chronic Hepatitis B Virus Infection in Real-World Cohort
Bektas E., Yilmaz A., Kikili C. I., Nuriyev K., Istemihan Z., Senkal I. V., et al.
International Journal of Hepatology
, cilt.2025, sa.1, 2025 (ESCI)
2025
202515. What are the predictors of malignancy in inflammatory bowel disease?
İstemihan Z., Çavuş B., Bardak A. E., Kirkoğlu A. M., Kiziltaş C., Silay R., et al.
Turkish Journal of Medical Sciences
, cilt.55, sa.4, ss.846-854, 2025 (SCI-Expanded)
2024
202416. Aceruloplasminemia as a rare hereditary disease: four case reports in a single center
İstemihan Z., İmanov Z., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., Beşışık S. F., et al.
Baylor University Medical Center Proceedings , sa.0, ss.1-4, 2024 (Scopus)
2024
202417. The Consequences of HLA Screening in the Prevention of Graft-Versus-Host Disease in Living Donor Liver Transplantation
Ercan L. D., DURMAZ Ö., KAYMAKOĞLU S., ÖNAL Z., Buyukbabani N., GÜLLÜOĞLU M., et al.
PEDIATRIC TRANSPLANTATION
, cilt.28, sa.6, 2024 (SCI-Expanded)
2024
202418. Functional Bowel Disorder Management in Routine Practice with Tips for Hot Topics: Expert Opinion Review
Akyuz F., ÇELEBİ A., Doǧan I., ERZİN Y. Z., KAV T., SOYTÜRK M., et al.
Turkish Journal of Gastroenterology
, cilt.35, sa.6, ss.423-439, 2024 (SCI-Expanded)
2023
202319. Two Cases of Malignant Transformation in Crohn’s Disease with Perianal Involvement
DAĞCI G., VARELCİ S., BÜYÜK M., ÇAVUŞ B., ÇİFCİBAŞI ÖRMECİ A., AKYÜZ F., et al.
Kare Publishing , cilt.2, 2023 (Hakemli Dergi)
2023
202320. Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study
Artan A. S., Mirioğlu Ş., İstemihan Z., Aksoy E., Dirim A. B., Çavuş B., et al.
BALKAN MEDICAL JOURNAL
, cilt.40, sa.3, ss.182-187, 2023 (SCI-Expanded)
2023
202321. Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?
Evirgen S., ÇAVUŞ B., Gokturk S., Iliaz R., ÖZKAN Z. G., Baran B., et al.
Hepatology Forum
, cilt.4, sa.3, ss.103-107, 2023 (Scopus)
2022
202222. Different Faces of Eosinophilic Infiltration of Gastrointestinal System
İSTEMİHAN Z., ÇAVUŞ B., BERKER N., Nuriyev K., Şenkal V., İmanov Z., et al.
Journal of Enterocolitis , cilt.1, sa.3, ss.68-71, 2022 (Hakemli Dergi)
2022
202223. Mucocutaneous Manifestations and Associated Factors in Patients with Crohn's Disease
Kayar Y., Dertli R., Konür Ş., Ağın M., Al Kafee A., Baran B., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.33, sa.11, ss.945-954, 2022 (SCI-Expanded)
2022
202224. SINGLE CENTER EXPERIENCE OF WILSON DISEASE
Demir K., Ormeci A. C., Cavus B., Akyuz F., Besisik F., Kaymakoglu S.
HEPATOLOGY
, cilt.76, 2022 (SCI-Expanded)
2022
202225. What is the effect of subepithelial lesions of the esophagus on esophageal motility?
Oermeci A., Cavus B., Akas R., Istemihan Z., Imanov Z., Senkal V., et al.
European review for medical and pharmacological sciences
, cilt.26, sa.17, ss.6300-6309, 2022 (SCI-Expanded)
2022
202226. Cell-free methylation of RASSF1 and CDKN2AIP genes in the diagnosis of hepatocellular carcinoma associated with hepatitis B virus cirrhosis
Telli P., Ozturk N. B., Hakan M. T., Cavus B., Ormeci A. C., Yakut A., et al.
HEPATOLOGY FORUM
, cilt.3, sa.3, ss.77-81, 2022 (ESCI)
2022
202227. Eliminating Viral Hepatitis in Turkey: Achievements and Challenges
AKARCA U. S., BAYKAM N., GÜNER H. R., GÜNŞAR F., İDİLMAN R., Kaymakoglu S., et al.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
, sa.2, ss.47-54, 2022 (ESCI)
2022
202228. Is anterior segment OCT superior to slit-lamp biomicroscopic examination for Kayser Flesicher ring in Wilson's disease?
Ormeci A., Bayraktar S., Isik A. O., Cavus B., Akas R., Istemihan Z., et al.
European review for medical and pharmacological sciences
, cilt.26, sa.14, ss.5178-5185, 2022 (SCI-Expanded)
2022
202229. Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center
Evirgen S., Iliaz R., Akyuz F., Cavus B., Gokturk S., Ormeci A., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.33, sa.6, ss.463-469, 2022 (SCI-Expanded)
2022
202230. A Case of Budd-Chiari Syndrome Associated With Antiphospholipid Syndrome Treated Successfully by Transjugular Intrahepatic Portosystemic Shunt
Torun E. S., Erciyestepe M., Yalcinkaya Y., Gul A., Inanc M., Ocal L., et al.
CLINICAL MEDICINE INSIGHTS-CASE REPORTS
, cilt.15, 2022 (ESCI)
2022
202231. Are Hepatobiliary Manifestations Related to the Site of Involvement in Inflammatory Bowel Disease?
İstemihan Z., Çifcibaşı Örmeci A., Çavuş B., Şenkal İ. V., İmanov Z., Nuriyev K., et al.
Journal of Enterocolitis , cilt.1, ss.12-16, 2022 (Hakemli Dergi)
2022
202232. Is Having Inflammatory Bowel Disease a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2?
Çavuş B., Akyüz F., Örmeci Çifçibaşı A., Özgür İ., Erel C., Yakut A., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.33, sa.3, ss.196-204, 2022 (SCI-Expanded)
2022
202233. Evaluation of safety and efficacy of tenofovir disoproxil in hemodialysis and renal transplant patients monoinfected with hepatitis B virus based on real life data.
Akyüz F., Çavuş B., Nizam N., Göktürk S., Baran B., Yazıcı H., et al.
Clinical and experimental hepatology
, cilt.8, sa.1, ss.7-13, 2022 (Hakemli Dergi)
2022
202234. EVALUATION OF HELICOBACTER PYLORI FREQUENCY AND GASTRIC ANTRUM PATHOLOGY FINDINGS IN PATIENTS WITH PORTAL HYPERTENSION
Cavus B., Ormeci A., Evirgen S., Iliaz R., Atasoy A., Yegen G., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.85, sa.2, ss.211-215, 2022 (ESCI)
2022
202235. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?
Cavus B., Akyuz F., Iliaz R., Atasoy A., Akyuz U., Demir K., et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
, cilt.36, 2022 (SCI-Expanded)
2022
202236. A mysterious cause of recurrent acute liver dysfunction for over a decade
Dirim A. B., Kalayci T., Guzel Dirim M., Demir S., Cavus B., Cifcibasi Ormeci A., et al.
GASTROENTEROLOGY REPORT
, cilt.10, 2022 (SCI-Expanded)
2022
202237. Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological Study
BAKKALOĞLU O. K., Yildirim O., Cavus B., Evirgen S., Gokturk S., Ormeci A., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.66, sa.1, 2022 (SCI-Expanded)
2021
202138. Prevalence and Association of Restless Leg Syndrome, Depression and Anxiety in Patients With Inflammatory Bowel Disease
Iliaz R., Ozturk N. B., Kilicarslan A. F., Akas R., Guzey D. Y., Senel E., et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY
, cilt.116, 2021 (SCI-Expanded)
2021
202139. Complementary Roles of Cadaveric and Living Donor Liver Transplantation in Acute Liver Failure.
Özden İ., Yavru H. A., Durmaz Ö., Orhun G., Salmaslıoğlu A., Güllüoğlu M., et al.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
, cilt.25, sa.10, ss.2516-2523, 2021 (SCI-Expanded, Scopus)
2021
202140. Is belching increasing after bariatric bypass surgery in the long term period?
Akyüz F., Göksoy B., Telli P., Nizam N., Atasoy A., Çavus B., et al.
Acta gastro-enterologica Belgica
, cilt.84, sa.4, ss.601-605, 2021 (SCI-Expanded)
2021
202141. Etiology of Cirrhosis in Turkey: A National Cohort Study
YILDIRIM A. E., ÜÇBİLEK E., Oruncu M. B., TURAN İ., DEMİR M., Koksal A., et al.
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded)
2021
202142. The development of extraintestinal manifestation and related risk factors in Crohn's patients
Kayar Y., Dertli R., Konur S., Agin M., Baran B., Ormeci A., et al.
IRISH JOURNAL OF MEDICAL SCIENCE
, cilt.190, sa.2, ss.597-604, 2021 (SCI-Expanded)
2021
202143. ATA Index: A novel score for predicting fibrosis stage in chronic viral hepatitis.
Tugsal H. Y., Yuksel S., Kabacam G., Evirgen S., Akan K., Akyuz F., et al.
Hepatology forum
, cilt.2, sa.1, ss.12-19, 2021 (ESCI)
2021
202144. Hepatocellular Carcinoma Metastasis to the Foot
Seyithanoglu D., Cavus B., Cifcibasi Ormeci A., Buyukbabani N., Poyanli A., Kaymakoglu S.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, cilt.36, sa.2, ss.234-235, 2021 (ESCI)
2021
202145. The case for simplifying and using absolute targets for viral hepatitis elimination goals
Razavi H., Blach S., Razavi-Shearer D., Abaalkhail F., Abbas Z., Abdallah A., et al.
Journal of Viral Hepatitis
, cilt.28, sa.1, ss.12-19, 2021 (SCI-Expanded)
2020
202046. Steroid-induced reconstitution of the biliary tree ravaged by IgG4-related disease
Ozden I., Poyanli A., Sanli Y., Kaymakoglu S.
CLINICAL CASE REPORTS
, cilt.8, sa.12, ss.3553-3554, 2020 (ESCI)
2020
202047. The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists
Kabacam G., Dayangac M., ÜÇBİLEK E., Ercin C. N., Gunsar F., Akyilchz M., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.31, sa.5, ss.348-355, 2020 (SCI-Expanded)
2020
202048. A micro-elimination approach to addressing hepatitis C in Turkey
İDİLMAN R., Razavi H., Robbins-Scott S., AKARCA U. S., ÖRMECİ N., Kaymakoglu S., et al.
BMC HEALTH SERVICES RESEARCH
, cilt.20, sa.1, 2020 (SCI-Expanded)
2020
202049. The effect of liver test abnormalities on the prognosis of COVID-19.
Medetalibeyoglu A., Catma Y., Senkal N., Ormeci A., Cavus B., Kose M., et al.
Annals of hepatology
, cilt.19, sa.6, ss.614-621, 2020 (SCI-Expanded, Scopus)
2019
201950. Changing epidemiology of chronic hepatitis C: patients are older and at a more advanced stage at the time of diagnosis
Iliaz R., Yuce T., Torun S., Cavus B., Gulluoglu M., Bozaci M., et al.
European journal of gastroenterology & hepatology
, cilt.31, sa.10, ss.1247-1249, 2019 (SCI-Expanded)
2019
201951. Risk factors associated with progression to intestinal complications of Crohn disease
Kayar Y., Baran B., Ormeci A., Akyuz F., Demir K., Besisik F., et al.
CHINESE MEDICAL JOURNAL
, cilt.132, sa.20, ss.2423-2429, 2019 (SCI-Expanded)
2019
201952. THE ASSESSMENT OF RENAL TRANSPLANT PATIENTS REGARDING MICRO-ELIMINATION OF CHRONIC VIRAL HEPATITISES IN TURKEY: AN ANALYSIS OF 2410 PATIENTS
Turkmen A., Bakir E. A., Bolukbas C., Sinangil A., Kocak E., Uyar M., et al.
TRANSPLANT INTERNATIONAL
, cilt.32, ss.194, 2019 (SCI-Expanded)
2019
201953. The Clinical Significance of JAK2V617F Mutation for Philadelphia-Negative Chronic Myeloproliferative Neoplasms in Patients with Splanchic Vein Thrombosis
Hindilerden F., Hindilerden I. Y., Pinarbasi B., HANÇER V. S., Kaymakoglu S., Kucukkaya R. D., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, 2019 (SCI-Expanded)
2019
201954. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?
Akyuz F., Cavus B., Iliaz R., Soyer O. M., Ormeci A., Evirgen S., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.31, sa.7, ss.777-780, 2019 (SCI-Expanded)
2019
201955. Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?
Akyuz F., Cavus B., Pinarbasi B., Bozaci M., Baran B., Akyuz U., et al.
Annals of Hepatology
, cilt.18, sa.4, ss.585-589, 2019 (SCI-Expanded)
2019
201956. Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort
İDİLMAN R., DEMİR M., ALADAĞ M., Erol C., Cavus B., Iliaz R., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.26, sa.6, ss.666-674, 2019 (SCI-Expanded)
2019
201957. Evaluation of drug resistance mutations in patients with chronic hepatitis B
Alaçam S., Karabulut N., Yolcu A., Onel M., Atasoy A., Kaymakoglu S., et al.
FOLIA MICROBIOLOGICA
, cilt.64, sa.2, ss.237-243, 2019 (SCI-Expanded)
2018
201858. Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes?
İLIAZ R., AKYÜZ F., Yeğen G., ÖRMECI A., GÖKTÜRK S., AKYÜZ Ü., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.29, sa.4, ss.384-391, 2018 (SCI-Expanded)
2018
201859. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Razavi-Shearer D., Gamkrelidze I., Nguyen M. H., Chen D., Van Damme P., Abbas Z., et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY
, cilt.3, sa.6, ss.383-403, 2018 (SCI-Expanded)
2018
201860. Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report
AYGEN B., DEMİR A. M., GÜMÜŞ M., Karabay O., Kaymakoglu S., KÖKSAL A. Ş., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.29, sa.3, ss.259-269, 2018 (SCI-Expanded)
2018
201861. Mutations in Core Gene Region of Hepatitis B Virus in Patients with Chronic Hepatitis B.
Ciftci S., Keskin F., Abaci N., Akyuz F., Cakiris A., Badur S., et al.
Clinical laboratory
, cilt.64, ss.303-310, 2018 (SCI-Expanded)
2018
201862. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma
Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Evirgen S., et al.
WORLD JOURNAL OF HEPATOLOGY
, cilt.10, sa.1, ss.51-61, 2018 (ESCI)
2018
201863. Serum Glypican-3, Vascular Endothelial Growth Factor, and lnterleukin-6 Levels in Hepatocellular Carcinoma
Serilmez M., Akyuz F., Ormeci Ciftcibasi A., Karabulut S., Kaymakoglu S., Yasasever V., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, cilt.33, sa.1, ss.18-27, 2018 (ESCI)
2018
201864. Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers
Iliaz R., Ozpolat T., Baran B., Demir K., Kaymakoglu S., Besisik F., et al.
European Journal of Gastroenterology and Hepatology
, cilt.30, sa.7, ss.786-791, 2018 (SCI-Expanded)
2017
201765. Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines
Tabak F., Yurdaydin C., KAYMAKOĞLU S., Tabak F., AKARSU M., Akinci E. G., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, 2017 (SCI-Expanded)
2017
201766. Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines
Yurdaydin C., Tabak F., KAYMAKOĞLU S., Tabak F., AKARSU M., Akinci E. G., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, 2017 (SCI-Expanded)
2017
201767. Turkey 2017 Clinical Practice Guidelines on recommendations for screning diagnosing and managing hepatitis C virus
Idilman R., Baykam N., KAYMAKOĞLU S., Tabak F., Bahcecioglu H. I., Bektas A., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, 2017 (SCI-Expanded)
2017
201768. Recommendation for treatment of hepatitis C virus infection
KAYMAKOĞLU S., Koksal I., KAYMAKOĞLU S., Tabak F., Akarca U. S., Akbulut A., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, 2017 (SCI-Expanded)
2017
201769. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study
Blach S., Zeuzem S., Manns M., Altraif I., Duberg A., Muljono D. H., et al.
The Lancet Gastroenterology and Hepatology
, cilt.2, sa.3, ss.161-176, 2017 (Scopus)
2017
201770. Belching in irritable bowel syndrome: An impedance study
Obekli T., Akyuz F., Akyuz U., Arici S., Iliaz R., Gokturk S., et al.
Journal of Neurogastroenterology and Motility
, cilt.23, sa.3, ss.409-414, 2017 (SCI-Expanded)
2017
201771. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts A retrospective cohort study
Soyer O. M., Baran B., Ormeci A., Sahin D., Gokturk S., Evirgen S., et al.
MEDICINE
, cilt.96, sa.1, 2017 (SCI-Expanded)
2017
201772. Analysis of hepatitis C virus NS5A region in patients with cirrhosis using an ultra-deep pyrosequencing method
Keskin F., Ciftci S., Akyuz F., Abaci N., Cakiris A., Akyuz U., et al.
Clinical Laboratory
, cilt.63, sa.9, ss.1439-1445, 2017 (SCI-Expanded)
2016
201673. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma
Iliaz R., Akyuz U., Tekin D., Serilmez M., Evirgen S., Cavus B., et al.
Arab Journal of Gastroenterology
, cilt.17, sa.4, ss.164-167, 2016 (SCI-Expanded, Scopus)
2016
201674. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels
Ormeci A., Aydın Y., Sumnu A., Baran B., Soyer O. M., Pinarbasi B., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
, cilt.52, ss.68-73, 2016 (SCI-Expanded)
2016
201675. Retention during capsule endoscopy: Is it a real problem in routine practice?
Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, cilt.44, sa.4, ss.968-975, 2016 (SCI-Expanded)
2016
201676. Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?
Iliaz S., Iliaz R., Onur S. T., Arici S., Akyuz U., Karaca C., et al.
Respiratory Medicine
, cilt.115, ss.20-25, 2016 (SCI-Expanded)
2016
201677. Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study
Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., Onel D., et al.
POSTGRADUATE MEDICINE
, cilt.128, sa.4, ss.432-438, 2016 (SCI-Expanded)
2016
201678. Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?
ORMECI A., Emrence Z., BARAN B., SOYER O., GOKTURK S., EVIRGEN S., et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
, cilt.20, sa.9, ss.1795-1797, 2016 (SCI-Expanded)
2016
201679. What is the impact of capsule endoscopy in the long term period?
Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.
WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY
, cilt.8, sa.7, ss.344-348, 2016 (ESCI)
2016
201680. Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole
Ormeci A., Emrence Z., Baran B., Gokturk S., Soyer O. M., Evirgen S., et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
, cilt.20, sa.5, ss.879-885, 2016 (SCI-Expanded)
2016
201681. Viral hepatitis screening guideline before biological drug use in rheumatic patients
KARADAĞ Ö., Kasifoglu T., Ozer B., Kaymakoglu S., KUS Y., Inanc M., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY
, cilt.3, sa.1, ss.25-28, 2016 (ESCI)
2016
201682. Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection
Ormeci A., Akyuz F., BARAN B., SOYER O., GÖKTÜRK S., ONEL M., et al.
European Review for Medical and Pharmacological Sciences
, cilt.20, sa.5, ss.858-865, 2016 (SCI-Expanded)
2015
201583. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study
Tozun N., Ozdogan O., Cakaloglu Y., Idilman R., Karasu Z., Akarca U., et al.
CLINICAL MICROBIOLOGY AND INFECTION
, cilt.21, sa.11, ss.1020-1026, 2015 (SCI-Expanded)
2015
201584. Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus
Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.
LIVER INTERNATIONAL
, cilt.35, sa.10, ss.2265-2274, 2015 (SCI-Expanded)
2015
201585. ROLE OF THE TACROLIMUS IN POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
Orhan E. K., Alpsan H., Bebek N., Pinarbasi B., Kaymakoglu S., Ozden I., et al.
NOBEL MEDICUS
, cilt.11, sa.3, ss.80-83, 2015 (ESCI)
2015
201586. Role of the tacrolimus in posterior reversible encephalopathy syndrome Posterior Geri Dönüşümlü Ensefalopati Sendromunda Tacrolimus’un Rolü
Orhan E., ALPSAN H., BEBEK N., PINARBAŞI B., KAYMAKOĞLU S., ÖZDEN İ., et al.
Nobel Medicus
, cilt.11, sa.3, ss.80-83, 2015 (Scopus)
2014
201487. In Situ Adenocarcinoma of the Ileum in Crohn’s Disease: A Possible Link with Latent CMV Infection?
KAYMAKOĞLU S., Baran B., Goksel S., Ince U., BAKIR B., Bugra D., et al.
Journal of Gastrointestinal Cancer
, cilt.45, sa.1, ss.252-256, 2014 (Scopus)
2014
201488. Treatment of Hepatocellular Cancer Due to Hepatitis Delta with Yttrium-90 Radioembolization in a Patient with Cirrhosis: A Case Report
UYANIKOĞLU A., AKYÜZ F., Ermis F., KAYMAKOĞLU S.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
, cilt.20, sa.3, ss.131-133, 2014 (ESCI)
2014
201489. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening
Demir A., Akyuz F., Gokturk S., Evirgen S., Akyuz U., Ormeci A., et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
, cilt.49, sa.12, ss.1414-1418, 2014 (SCI-Expanded)
2014
201490. Effects of Polymorphisms in Interferon lambda 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection
Yilmaz E., Baran B., Soyer O. M., Onel M., Onel D., Ormeci A., et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
, cilt.12, sa.10, ss.1753-1758, 2014 (SCI-Expanded)
2014
201491. Infliximab in inflammatory bowel disease: attention to adverse events
Uyanikoglu A., Ermis F., Akyuz F., Pinarbasi B., Baran B., Aydogan T., et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
, cilt.18, sa.16, ss.2337-2342, 2014 (SCI-Expanded)
2014
201492. Acute hepatitis B due to immune-escape mutations in a naturally immune patient
Kaymakoglu S., Baran B., Onel D., Badur S., Atamer T., Akyuz F.
ACTA GASTRO-ENTEROLOGICA BELGICA
, sa.2, ss.262-265, 2014 (SCI-Expanded)
2014
201493. Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method
Ciftci S., Keskin F., Cakiris A., Akyuz F., Pinarbasi B., Abaci N., et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
, cilt.79, sa.1, ss.25-30, 2014 (SCI-Expanded)
2014
201494. Historical epidemiology of hepatitis C virus (HCV) in selected countries
Bruggmann P., Berg T., Ovrehus A. L. H., Moreno C., Brandao Mello C. E., Roudot-Thoraval F., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.21, ss.5-33, 2014 (SCI-Expanded)
2014
201495. Strategies to manage hepatitis C virus (HCV) disease burden
Wedemeyer H., Duberg A. S., Buti M., Rosenberg W. M., Frankova S., Esmat G., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.21, ss.60-89, 2014 (SCI-Expanded)
2014
201496. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
Razavi H., Waked I., Sarrazin C., Myers R. P., Idilman R., Calinas F., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.21, ss.34-59, 2014 (SCI-Expanded)
2014
201497. Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C
Baran B., Gulluoglu M., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.21, sa.2, ss.111-120, 2014 (SCI-Expanded)
2014
201498. Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B
KESKİN O., Ormeci A., Baran B., Kabacam G., Tuzun A., Karatayli E., et al.
ANTIVIRAL THERAPY
, cilt.19, sa.6, ss.543-550, 2014 (SCI-Expanded)
2013
201399. Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients
Mese S., Arikan M., Cakiris A., Abaci N., Gumus E., Kursun O., et al.
JOURNAL OF GENERAL VIROLOGY
, cilt.94, ss.2729-2738, 2013 (SCI-Expanded)
2013
2013100. Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C
Uyanikoglu A., Akyuz F., Baran B., Simsek B. P., Ermis F., Demir K., et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
, cilt.37, sa.5, ss.485-490, 2013 (SCI-Expanded)
2013
2013101. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients
Avsar E., TIFTIKCI A., Poturoglu S., Erzin Y., KOCAKAYA O., DİNÇER D., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.24, sa.4, ss.316-321, 2013 (SCI-Expanded)
2013
2013102. Rosai-Dorfman disease with diffuse gastrointestinal involvement
Baran B., Karaca C., Soyer O. M., Yonal I., Isiklar A. D., Cakmak R., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.25, sa.7, ss.869-874, 2013 (SCI-Expanded)
2013
2013103. Durability of sustained virologic response in chronic hepatitis C
UYANIKOĞLU A., Kaymakoglu S., Danalioglu A., Akyuz F., Ermis F., Pinarbasi B., et al.
Gut and Liver
, cilt.7, sa.4, ss.458-461, 2013 (SCI-Expanded)
2013
2013104. Effect of Genotypic Differences in CYP2C19 and on Cure Rates for Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors
Demir K., ORMECI A., Emrence Z., Gokturk S., Baran B., SOYER O. M., et al.
GASTROENTEROLOGY
, cilt.144, sa.5, 2013 (SCI-Expanded)
2013
2013105. Efficacy of Tenofovir in Patients with Lamivudine Failure Is Not Different from That in Nucleoside/Nucleotide Analogue-Naive Patients with Chronic Hepatitis B
Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Bozbey H. U., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.57, sa.4, ss.1790-1796, 2013 (SCI-Expanded)
2013
2013106. Association of the MEFV Gene Variations With Inflammatory Bowel Disease in Turkey
Akyuz F., Besisik F., Ustek D., Ekmekci C., Uyar A., Pinarbasi B., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.47, sa.3, 2013 (SCI-Expanded)
2013
2013107. Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response
Karaca C., Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., et al.
ANTIVIRAL THERAPY
, cilt.18, sa.4, ss.561-566, 2013 (SCI-Expanded)
2012
2012108. Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease
Pinarbasi B., Demir K., Oflaz H., Ahishali E., Akyuz F., Elitok A., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.23, sa.6, ss.720-726, 2012 (SCI-Expanded)
2012
2012109. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis
Yonal I., Pinarbasi B., Hindilerden F., Hancer V. S., Nalcaci M., Kaymakoglu S., et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
, cilt.34, sa.3, ss.388-396, 2012 (SCI-Expanded)
2012
2012110. Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins
Le Gal F., Badur S., Al Hawajri N., Akyuz F., Kaymakoglu S., Brichler S., et al.
ARCHIVES OF VIROLOGY
, cilt.157, sa.4, ss.647-659, 2012 (SCI-Expanded)
2012
2012111. Etiological factors of duodenal and gastric ulcers
Uyanikoglu A., Danalioglu A., Akyuz F., Ermis F., Gulluoglu M., Kapran Y., et al.
Turkish Journal of Gastroenterology
, cilt.23, sa.2, ss.99-103, 2012 (SCI-Expanded)
2012
2012112. Should maintenance therapy be performed in ulcerative proctitis? How long should it be continued?
Yonal O., Hatemi G., Kaymakoglu S.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.23, ss.21-24, 2012 (SCI-Expanded)
2011
2011113. Second-Line Levofloxacin-Based Triple Therapy's Efficiency for Helicobacter pylori Eradication in Patients With Peptic Ulcer
Ermis F., Akyuz F., Uyanikoglu A., Kurt R., Pinarbasi B., Nazik H., et al.
SOUTHERN MEDICAL JOURNAL
, cilt.104, sa.8, ss.579-583, 2011 (SCI-Expanded)
2011
2011114. Postprandial platelet-poor plasma 5-hydroxytryptamine concentrations during diarrhea and constipation periods of alternatingtype irritable bowel syndrome patients
Sen F., Pinarbasi B., Issever H., Akyuz F., Mungan Z., Kaymakoglu S.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.22, sa.3, ss.270-278, 2011 (SCI-Expanded)
2011
2011115. Anticoagulant therapy and Budd-Chiari syndrome: Is it successful?
Akyuz F., Cakaloglu Y., Pinarbasi B., Demir K., Akyuz U., Ozdil S., et al.
Hepato-Gastroenterology
, cilt.58, ss.900-903, 2011 (SCI-Expanded)
2011
2011116. Effect of proton pump inhibitor (PPI) treatment in obstructive sleep apnea syndrome: An esophageal impedance-pHmetry study
Ermis F., Akyuz F., Arici S., Uyanikoglu A., Yakar F., Pinarbasi B., et al.
Hepato-Gastroenterology
, cilt.58, ss.1566-1573, 2011 (SCI-Expanded)
2011
2011117. A rare complication of interferon treatment: optic neuropathy
Gokturk S., Atay K., ÇİFCİBAŞI ÖRMECİ A., Baran B., Soyer O. M., AKYÜZ F., et al.
ANNALS OF GASTROENTEROLOGY
, cilt.24, sa.4, ss.335, 2011 (ESCI)
2010
2010118. Decreased prohepcidin levels in patients with HBV-related liver disease: relation with ferritin levels.
Yonal O., Akyuz F., Demir K., Ciftci S., Keskin F., Pinarbasi B., et al.
Digestive diseases and sciences
, cilt.55, sa.12, ss.3548-51, 2010 (SCI-Expanded)
2010
2010119. Is portal hypertensive enteropathy an important additional cause of blood loss in portal hypertensive patients?
Akyuz F., Pinarbasi B., Ermis F., Uyanikoglu A., Demir K., Ozdil S., et al.
Scandinavian Journal of Gastroenterology
, cilt.45, sa.12, ss.1497-1502, 2010 (SCI-Expanded)
2010
2010120. How should we follow the Crohn's disease patients in remission?
Yonal O., Kaymakoglu S.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.21, sa.1, ss.97-99, 2010 (SCI-Expanded)
2010
2010121. Electron microscopic findings in non-alcoholic fatty liver disease: Is there a difference between hepatosteatosis and steatohepatitis?
Ahishali E., Demir K., Ahishali B., Akyuz F., Pinarbasi B., Poturoglu S., et al.
Journal of Gastroenterology and Hepatology (Australia)
, cilt.25, sa.3, ss.619-626, 2010 (SCI-Expanded)
2009
2009122. The quality of life in hemodialysis patients with chronic hepatitis C virus infection
Akyuz F., Besisik F., Pinarbasi B., Demir K., Kaymakoglu S., Cakaloglu Y., et al.
Turkish Journal of Gastroenterology
, cilt.20, sa.4, ss.243-246, 2009 (SCI-Expanded)
2009
2009123. A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients
Idilman R., Kaymakoglu S., Onder F. O., Ahishali E., Bektas M., Cinar K., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.16, sa.4, ss.279-285, 2009 (SCI-Expanded)
2009
2009124. Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy
Shouval D., Lai C., Chang T., Cheinquer H., Martin P., Carosi G., et al.
JOURNAL OF HEPATOLOGY
, cilt.50, sa.2, ss.289-295, 2009 (SCI-Expanded)
2009
2009125. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?
Pinarbasi B., Kalymakoglu S., Matur Z., Akyuz F., Demir K., Besisik F., et al.
Journal of clinical gastroenterology
, cilt.43, sa.2, ss.176-81, 2009 (SCI-Expanded)
2009
2009126. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey.
Pinarbasi B., Onel D., Cosan F., Akyuz F., Dirlik N., Cakaloglu Y., et al.
Liver international : official journal of the International Association for the Study of the Liver
, cilt.29, sa.2, ss.227-30, 2009 (SCI-Expanded)
2009
2009127. MASSIVE BLEEDING DUE TO PARACENTESIS-ACASE REPORT
Kocabay G., Tiryaki B., Sumnu A., Gul E., KAYMAKOĞLU S.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.72, sa.2, ss.55-57, 2009 (ESCI)
2009
2009128. Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a
Marcellin P., Bonino F., Lau G. K., Farci P., Yurdaydin C., Piratvisuth T., et al.
Gastroenterology
, cilt.136, sa.7, 2009 (SCI-Expanded)
2009
2009129. A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease
Poturoglu S., Kaymakoglu S., Polat N. G., Ibrisim D., Ahishali E., Akyuz F., et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
, cilt.69, sa.6, ss.696-702, 2009 (SCI-Expanded)
2008
2008130. Intestinal metaplasia in portal hypertensive gastropathy: A frequent pathology
Ibrisim D., Cevikbas U., Akyuz F., Poturoglu S., Ahishali E., Gulluoglu M., et al.
European Journal of Gastroenterology and Hepatology
, cilt.20, sa.9, ss.874-880, 2008 (SCI-Expanded)
2008
2008131. Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus
Okan G., Yaylaci S., Peker O., Kaymakoglu S., Saruc M.
WORLD JOURNAL OF GASTROENTEROLOGY
, cilt.14, sa.29, ss.4697-4700, 2008 (SCI-Expanded)
2008
2008132. Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey
Cakaloglu Y., Akyuez F., Bozaci M., Ibrisim D., Pinarbasi B., Demir K., et al.
Turkish Journal of Gastroenterology
, cilt.19, sa.2, ss.104-108, 2008 (SCI-Expanded)
2008
2008133. Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologie, biochemical, and serology outcomes through 96 weeks
Sherman M., Yurdaydin C., Simsek H., Silva M., Liaw Y., Rustgi V. K., et al.
Hepatology
, cilt.48, sa.1, ss.99-108, 2008 (SCI-Expanded)
2008
2008134. Peptic ulcer disease: What did change in Turkey?
Yazici A., AKYÜZ F., İŞSEVER H., Pinarbasi B., DEMİR K., Ozdil S., et al.
GASTROENTEROLOGY
, cilt.134, sa.4, 2008 (SCI-Expanded)
2008
2008135. MEFV gene mutations and inflammatory bowel disease: Is there any effect?
AKYÜZ F., Besisik F., Pinarbasi B., DEMİR K., KAYMAKOĞLU S., Ozdil S., et al.
GASTROENTEROLOGY
, cilt.134, sa.4, 2008 (SCI-Expanded)
2008
2008136. A rare cause of hemosuccus pancreaticus: Primary splenic artery aneurysm ruptured into pancreatic serous cystadenoma
Pinarbasi B., Poturoglu S., Yanar H., Gueven K., Akyuez F., Dizdaroglu F., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.19, sa.1, ss.57-63, 2008 (SCI-Expanded)
2007
2007137. Somatostatin and propranolol to treat small-for-size syndrome that occurred despite splenic artery ligation
Oezden I., Kara M., Pinarbasi B., Salmaslioglu A., Yavru A., Kaymakoglu S., et al.
EXPERIMENTAL AND CLINICAL TRANSPLANTATION
, cilt.5, sa.2, ss.686-689, 2007 (SCI-Expanded)
2007
2007138. HFE gene mutation, chronic liver disease, and iron overload in Turkey
YOENAL O., Hatirnaz O., AKYUEZ F., Oezbek U., Demir K., Kaymakoglu S., et al.
DIGESTIVE DISEASES AND SCIENCES
, cilt.52, sa.11, ss.3298-3302, 2007 (SCI-Expanded)
2007
2007139. The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease
Akyuez F., Demir K., Oezdil S., Aksoy N., Poturoglu S., Ibrisim D., et al.
Digestive Diseases and Sciences
, cilt.52, sa.9, ss.2359-2367, 2007 (SCI-Expanded)
2007
2007140. A case of Aeromonas hydrophila enteritis in the course of ulcerative colitis
Ahishali E., Pinarbasi B., Akyuz F., Ibrisim D., Kaymakoglu S., Mungan Z.
EUROPEAN JOURNAL OF INTERNAL MEDICINE
, cilt.18, sa.5, ss.430-431, 2007 (SCI-Expanded)
2007
2007141. Pegylatedd interferon alfa-2b monotherapy and pegylated interferon alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B
Kaymakoglu S., Oguz D., Gur G., Gurel S., Tankurt E., Ersoz G., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.51, sa.8, ss.3020-3022, 2007 (SCI-Expanded)
2007
2007142. Ülseratif Kolitte Cerrahi Tedavinin Hastaların Yaşam Kalitesi Üzerindeki Etkilerinin Değerlendirilmesi
AKYÜZ N., BALIK E., KANAN N., YAMANER S., KAYMAKOĞLU S., AKYÜZ A., et al.
Kolon ve Rektum Hast Derg , sa.17, ss.88-101, 2007 (Hakemli Dergi)
2007
2007143. Eosinophilic esophagitis: Case report
Mungan Z., Pinarbasi B., Kaymakoglu S.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.18, sa.2, ss.100-102, 2007 (SCI-Expanded)
2007
2007144. Kronik Hepatit C’li hastalarda, Genotip 1b dışındaki genotiplerle infeksiyonun, lineprrobe assay 5’ UTR ve NS5B bölgesinin Dizilenmesi Yöntemleri ile Araştırılması.
KESKİN F., KAYMAKOĞLU S., Türkoğlu S.
Moleküler tanı dergisi
, cilt.3, sa.2, ss.40-44, 2007 (Hakemli Dergi)
2007
2007145. What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?
Demir K., Akyuz F., Ozdil S., Aksoy N., Kaymakoglu S., Poturoglu S., et al.
Annals of Hepatology
, cilt.6, sa.2, ss.92-96, 2007 (Scopus)
2007
2007146. Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B
Kaymakoglu S., Danalioglu A., Demir K., Karaca C., Akyuz F., Onel D., et al.
Digestive Diseases and Sciences
, cilt.52, sa.3, ss.727-731, 2007 (SCI-Expanded)
2007
2007147. PERNICIOUS ANEMIA ASSOCIATED WITH CRYPTOGENIC CIRRHOSIS
Cosan F., Pinarbasi B., Ibrisim D., GÜLLÜOĞLU M., DEMİR K., KAYMAKOĞLU S., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.70, sa.4, ss.107-110, 2007 (ESCI)
2007
2007148. Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy
Akyuz F., Kaymakoglu S., Demir K., Aksoy N., Karaca C., Danalioglu A., et al.
Acta Gastro-Enterologica Belgica
, cilt.70, sa.1, ss.20-24, 2007 (SCI-Expanded)
2005
2005149. Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels
Akyuz F., Polat N., Kaymakoglu S., Aksoy N., Demir K., Besisik F., et al.
World Journal of Gastroenterology
, cilt.11, sa.45, ss.7188-7191, 2005 (SCI-Expanded)
2005
2005150. Merkel-cell carcinoma arising after liver transplantation: A case report
Esen B., PINARBASI B., Buyukbabani N., Baykal C., Cizmeci O., Demir K., et al.
TRANSPLANTATION PROCEEDINGS
, cilt.37, sa.10, ss.4413-4415, 2005 (SCI-Expanded)
2005
2005151. Psychiatric morbidity and quality of life in chronic hepatitis patients
Ozkan M., Corapcioglu A., Balcioglu I., Ertekin E., Koroglu G., Ozdemir S., et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH
, cilt.59, sa.1, ss.42, 2005 (SCI-Expanded)
2005
2005152. Crohn disease activity evaluated by Doppler ultrasonography of the superior mesenteric artery and the affected small-bowel segments
YEKELER E., DANALIOGLU A., MOVASSEGHI B., YILMAZ S., KARACA C., KAYMAKOGLU S., et al.
JOURNAL OF ULTRASOUND IN MEDICINE
, cilt.24, sa.1, ss.59-65, 2005 (SCI-Expanded)
2005
2005153. Is there any medical therapeutic option in hepatopulmonary syndrome? A case report
AKYÜZ F., KAYMAKOĞLU S., DEMİR K., Aksoy N., Adalet I., Ökten A.
European Journal of Internal Medicine
, cilt.16, sa.2, ss.126-128, 2005 (Scopus)
2003
2003154. Interferon-alpha(2b) induction treatment with or without ribavirin in chronic hepatitis C - A multicenter, randomized, controlled trial
Senturk H., Ersoz G., Ozaras R., Kaymakoglu S., Bozkaya H., Akdogan M., et al.
DIGESTIVE DISEASES AND SCIENCES
, cilt.48, sa.6, ss.1124-1129, 2003 (SCI-Expanded)
2002
2002155. Coexistence of homozygous factor V Leiden mutation and antiphospholipid antibodies in two patients presented with Budd-Chiari syndrome
Diz-Kucukkaya R., Demir K., Yenerel M. N., Nalcaci M., Kaymakoglu S., Inanc M.
HAEMATOLOGIA
, cilt.32, sa.1, ss.73-77, 2002 (SCI-Expanded)
2001
2001156. Assay of Mycobacterium tuberculosis in biopsy specimens taken from hepatic granuloma patients using polymerase chain reaction method
Tuncer İ., KÖKSALAN O. K., DEMİR K., Dinçer D., TÜRKOĞLU S., KAYMAKOĞLU S., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.12, sa.3, ss.189-195, 2001 (Scopus)
2001
2001157. Miconazole induced acute hepatitis and sexual intercourse!
Beşişik F., Dinçer D., DEMİR K., KAYMAKOĞLU S., Çakalǒglu Y., Çevikbaş U., et al.
Turkish Journal of Gastroenterology
, cilt.12, sa.1, ss.59-63, 2001 (SCI-Expanded)
1992
1992158. Sağlık personeli olmak HCV infeksiyonu açısından risk faktörü mü ? Asemptomatik sağlık personelinde HCV seroprevalansı.
Beşışık F., Ökten A., Kaymakoğlu S., BADUR O. S., Yalçın S., AĞAÇFİDAN A.
Gastroenterohepatoloji , cilt.3, sa.3, ss.169-171, 1992 (Hakemli Dergi)
1992
1992159. Türkiyede sağlıklı bireyler ve akut-NANBH olgularında hepatit E virusu antikorlarının (anti-HEV) araştırılması.
Badur O. S., Dedeoğlu F. B., YENEN O. Ş., Yüksel D., Işık N. H., KAYMAKOĞLU S.
İNFEKSİYON DERGİSİ
, cilt.8, sa.1, ss.1-4, 1992 (Hakemli Dergi)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2025
20251. The Role of MicroRNA-192-5p in the Pathogenesis of Crohn's Disease
Orhan Dicle E., Genç Uluçeçen S., İstemihan Z., Çavuş B., Oğuz F., Kaymakoğlu S., et al.
38th uropean Federation for Immunogenetics Congress, Praha, Çek Cumhuriyeti, 14 - 17 Mayıs 2025, cilt.105, ss.84, (Özet Bildiri)
2024
20242. 10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good
İstemihan Z., Kemeç G., Cebeci T., Çetin O., Genç Uluçeçen S., Rüstemzade A., et al.
EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.803, (Özet Bildiri)
2024
20243. The relationship between spleen stiffness and portal hypertension liver transplant patients
Nurıyev K., İstemihan Z., Telli P., Qurbanov A., Yağlı M. A., Dağcı G., et al.
EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.377-378, (Özet Bildiri)
2024
20244. Steatotic liver disease in diabetic patients: more serious diabetes mellitus, more serious liver disease
İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., Nurıyev K., et al.
EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.551, (Özet Bildiri)
2024
20245. Clinical characteristics of patients with hereditary hemorrhagic telangiectasia: Real-life data, single-center experience
İstemihan Z., Bardak A. E., Nurıyev K., Rüstemzade A., Genç Uluçeçen S., Çavuş B., et al.
ESGE Days 2024, Berlin, Almanya, 25 - 27 Nisan 2024, ss.297, (Özet Bildiri)
2023
20236. Otoimmün Tanılı Hastalarda Viral Serolojik Profilin Değerlendirilmesi
Küçükkaya S., Çaklovica Küçükkaya İ., Çavuş B., Safran N., Önel M., Kırkoyun Uysal H., et al.
7. Ulusak Klinik Mikrobiyoloji Kongresi (KLİMUD), Muğla, Türkiye, 1 - 05 Kasım 2023, ss.635, (Özet Bildiri)
2023
20237. HYPERLIPIDEMIA, ATHEROSCLEROSIS AND HEPATOSTEATOSIS IN PRIMARY BILIARY CHOLANGITIS: WHAT IS THE RISK?
ÇOŞKUN A., Ormeci A. C., ÇAVUŞ B., ŞENKAL İ. V., KARAPINAR E., POYANLI A., et al.
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, (Özet Bildiri)
2023
20238. ARE THERE NEW PRACTICAL MARKERS TO PREDICT MALIGNANCY IN PANCREATIC CYST FLUIDS?
Anıl K. U., Çavuş B., Çifcibaşı Örmeci A., İmanov Z., Şenkal İ. V., Nurıyev K., et al.
Digestive Disease Week 2023, Washington, Amerika Birleşik Devletleri, 6 - 09 Mayıs 2023, ss.774, (Özet Bildiri)
2022
20229. Tedavi naif ve deneyimli Kronik Hepatit B hastalarında tenofovir alafenamidin gerçek yaşam verileri: daha fazla etki, daha az yan etki
Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.
39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 22 - 27 Kasım 2022, ss.1159-1162, (Özet Bildiri)
2022
202210. GRANÜLOMATÖZ HEPATİT VE İNTRAHEPATİK KOLESTAZA BAĞLI HİPERLİPİDEMİ İLE SEYREDEN AKCİĞER-DIŞI SARKOİDOZ OLGUSU
Bektaş E., Yılmaz A., Bilgin E., Mutlu Ü., Çavuş B., Çifcibaşı Örmeci A., et al.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 19 - 23 Ekim 2022, ss.136-137, (Tam Metin Bildiri)
2022
202211. REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS
Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.
AASLD Liver Meeting , District Of Columbia, Amerika Birleşik Devletleri, 4 - 08 Kasım 2022, cilt.76, ss.299, (Özet Bildiri)
2022
202212. Dekompanse karaciğer sirozunda ince barsak tutulumlu diffüz büyük b hücreli lenfoma olgusu
Teberik Kama E., İstemihan Z., Çifcibaşı Örmeci A., Akyüz F., Kaymakoğlu S.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 19 - 23 Ekim 2022, ss.140, (Özet Bildiri)
2022
202213. İshal ve kilo kaybının nadir bir nedeni:Amiloidoz
Çiftçi A. C., Konyaoğlu H., Şenkal İ. V., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., et al.
21. Çapa Gastroenteroloji Günleri, İstanbul, Türkiye, 31 Mart - 02 Nisan 2022, ss.70, (Tam Metin Bildiri)
2022
202214. BILATERAL FEMUR BAŞI AVASKÜLER NEKROZU ILE BAŞVURAN HEMOKROMATOZIS OLGUSU
Yılmaz A., Bektaş E., Gülseren Ü. A., Şenkal İ. V., Nurıyev K., Altınkaynak M., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2022, Sakarya, Türkiye, 23 - 27 Mart 2022, ss.38-39, (Tam Metin Bildiri)
2021
202115. Budd-Chiari Sendromu’nda Hepatoselüler Kanser ve Mortalitenin Değerlendirilmesi
İstemihan Z., Nurıyev K., Şenkal İ. V., İmanov Z., Sarıdal M. K., Akas R., et al.
38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2021, ss.219, (Özet Bildiri)
2021
202116. Ön Segment Optik Koherans Tomografi (OCT), Wilson hastalığı tanısında Kayser Fleischer Halkası varlığını değerlendirmeki yeri - Ehil oftalmolog gerekliliğine son verecek mi?
Çifcibaşı Örmeci A., Bayraktar Ş., Işık A. O., İstemihan Z., Sarıdal M. K., Akas R., et al.
38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2021, ss.218, (Özet Bildiri)
2020
202017. TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?
Kapar C., Cavus B., Atasoy A., Suleymanova V., Isik A., Karahan L., et al.
Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 Kasım 2020, cilt.72, (Özet Bildiri)
2019
201918. Bariyatrik by-pass cerrahisi sonrası uzun dönemde geğirti artıyor mu?
AKYÜZ F., TELLİ P., nizam n., GÖKSOY B., ATASOY A., ÇAVUŞ B., et al.
7. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 29 Kasım - 01 Aralık 2019, ss.99, (Özet Bildiri)
2019
201919. Is belching increasing after bariatric by-pass surgery in the long term period?
AKYÜZ F., GÖKSOY B., TELLİ P., NİZAM N., ATASOY A., ÇAVUŞ B., et al.
United European Gastroenterology (UEG) Week 2019, İspanya, 19 - 23 Ekim 2019, cilt.7, ss.703, (Özet Bildiri)
2019
201920. Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?
MİRİOĞLU Ş., ÇAKMAK DEMİR S., ILIAZ R., ÇELEN ÖGÜNÇ H., AKYÜZ F., DEMİR K., et al.
AASLD-TASL Connect Regional Meeting, İstanbul, Türkiye, 15 - 16 Mart 2019, cilt.30, ss.21-22, (Tam Metin Bildiri)
2019
201921. Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?
MİRİOĞLU Ş., ÇAKMAK DEMİR S., ILIAZ R., ÇELEN ÖĞÜNÇ H., AKYÜZ F., DEMİR K., et al.
AASLD-TASL Connect Regional Meeting, İstanbul, Türkiye, 15 - 16 Mart 2019, cilt.30, ss.21-22, (Özet Bildiri)
2018
201822. Clinical Impact of Endosonography in the Differantial Diagnosis of Indeterminate Biliary Strictures
Akyuz F., Deniz R., Karsli S., Akyuz U., Atasoy A., Demir K., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)
2018
201823. Is It Sufficient Only to Request an Anti-HCV Test for the Performance of HCV Screening?
Deniz R., Karsli S., Ekinci O. B., Kalantarova I., Atasoy A., Onel M., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)
2017
201724. Böbrek Nakli Alıcılarında Direkt Etkili Antivirallerle HCV Tedavisi
MİRİOĞLU Ş., İSTEMİHAN Z., ŞAHİN E., Aksoy E., DEMİR E., AKGÜL S., et al.
34. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, cilt.26, sa.3, ss.35, (Özet Bildiri)
2017
201725. Böbrek Nakli Alıcılarında Direkt Etkili Antivirallerle HCV Tedavisi
MİRİOĞLU Ş., İSTEMİHAN Z., ŞAHİN E., AKSOY E., DEMİR E., USTA AKGÜL S., et al.
34. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, cilt.26, ss.35, (Özet Bildiri)
2017
201726. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?
Akyuz F., Iliaz R., Cavus B., Atasoy A., Akyuz U., Demir K., et al.
68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 Ekim 2017, cilt.66, (Özet Bildiri)
2017
201727. Tens asitli siroz hastalarında intraabdominal hipertansiyonun prognoz üzerine etkisi
MUTLU Ü., ATASOY A., ILIAZ R., ÇAVUŞ B., AKYÜZ F., DEMİR K., et al.
11. Ulusal Hepatoloji Kongresi, Antalya, Türkiye, 17 - 21 Mayıs 2017, ss.31-32, (Özet Bildiri)
2017
201728. Vitamin D receptor gene polymorphisms may affect the interferon response in chronic hepatitis B patients
AKYÜZ F., UÇAR A. R., ÇİFTÇİ S., KESKİN F., ILIAZ R., ÇAVUŞ B., et al.
26th Annual Conference of APASL, Shanghai, Çin, 15 - 19 Şubat 2017, cilt.11, sa.1, (Tam Metin Bildiri)
2016
201629. Kronik hepatit C’li hastalar artık daha yaşlı ve daha ciddi karaciğer hastalığı ile kliniğe başvuruyor
ILIAZ R., YÜCE İNEL T., TORUN E. S., ÇAVUŞ B., GÜLLÜOĞLU M., Bozacı M., et al.
XIII. Ulusal Viral Hepatit Kongresi, Antalya, Türkiye, 17 - 20 Mart 2016, ss.18, (Tam Metin Bildiri)
2015
201530. Olgu sunumu: İmmünokompetan hastada dissemine tüberküloz lenfadenopatisi
DİRİM A. B., MİRİOĞLU Ş., ÇAVUŞ B., ILIAZ R., YILMAZBAYHAN E. D., AKYÜZ F., et al.
32. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 25 - 29 Kasım 2015, ss.94, (Tam Metin Bildiri)
2015
201531. Olgu sunumu: İmmünokompetan hastada dissemine tüberküloz lenfadenopatisi
DİRİM A. B., MİRİOĞLU Ş., ÇAVUŞ B., ILIAZ R., YILMAZBAYHAN E. D., AKYÜZ F., et al.
32. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 25 - 29 Kasım 2015, cilt.26, ss.94, (Özet Bildiri)
2015
201532. "Normal" Serum ALT/AST Level in Turkish Population
Karasu Z., Tozun N., İDİLMAN R., ÖZDOĞAN O. C., Kaymakoglu S., Cakaloglu Y., et al.
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62
2015
201533. Hepatitis C Seropositivity is not as high as Western Countries in the Population Born Between 1945-1965 According to Turkey Nationwide Hepatitis Prevalence Study (TURKHEP 2010)
ÖZDOĞAN O. C., Tozun N., Kaymakoglu S., İDİLMAN R., Karasu Z., AKARCA U. S.
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62
2015
201534. Cyclosporine Therapy As a Rescue Treatment in Acute Severe Ulcerative Colitis: A Real Life-Data From a Tertiary Center
Evirgen S., Iliaz R., AKYÜZ F., ÇAVUŞ B., Pinarbasi B. S., Karaca C., et al.
46th Annual Digestive Disease Week (DDW), Washington, Kiribati, 16 - 19 Mayıs 2015, cilt.148, (Özet Bildiri)
2015
201535. Hasta ortada kalmasın Multidisipliner yaklaşım
TÜKEK T., TANAKOL R., KAYMAKOĞLU S., YENEREL M. N., KÖSE M.
"Geleneksel İç Hastalıkları Günleri-İnteraktif Güncelleştirme - 2016", Türkiye, 11 - 13 Mart 2015
2014
201436. Chronic Renal Failure after Liver Transplantation in Long Term: Prevalence and Risk Factors.
Gokturk S., Baran B., Ormeci A., Soyer O., Evirgen S., Ozden I., et al.
Joint International Congress of ILTS, ELITA and LICAGE, London, Kanada, 4 - 07 Haziran 2014, cilt.20, (Özet Bildiri)
2014
201437. The Course of Pregnancy in Wilson's Disease-One Center, 20 Years' Experience
DEMİR K., Soyer O. M., Karaca C., BEŞIŞIK S. F., KAYMAKOĞLU S., BEŞIŞIK S. F.
55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Illinois, Amerika Birleşik Devletleri, 3 - 06 Mayıs 2014, cilt.146, (Özet Bildiri)
2013
201338. Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels
Ormeci A., Akyuz F., Baran B., Soyer O. M., Gokturk S., Karaca C., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri)
2013
201339. Safety of Tenofovir in Renal Transplanted and Hemodialysis Patients with Chronic Hepatitis B
Akyuz F., Gokturk S., Baran B., Ormeci A., Soyer O. M., Evirgen S., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)
2013
201340. Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus
Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri)
2013
201341. Virological Supression Does not Prevent the Development of Hepatocellular Carsinoma in Cirrhotic Patients with Genotype D Hepatitis B Infection
Gokturk S., Basar R., Ucar A. R., Basgoze B. H., Altinkaynak M., Buyukballi P., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)
2013
201342. The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B
Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri)
2013
201343. Baseline alfa-fetoprotein level is a strong predictor of vascular invasion and survival in patients with hepatocellular carcinoma
Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Poyanli A., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)
2013
201344. Does Chemoprophylaxis Prevent Tuberculosis Reactivation in the Long Term Period of Anti-TNF Treatment?
AKYÜZ F., Soyer O. M., Gokturk S., ÇİFCİBAŞI ÖRMECİ A., Evirgen S., Onder S. Y., et al.
Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, Amerika Birleşik Devletleri, 18 - 21 Mayıs 2013, cilt.144, (Özet Bildiri)
2012
201245. Number connection test-A and inhibitor control test are not efficient for diagnosis of minimal hepatic encephalopathy in cirrhotic patients
Baran B., Ozcan E., Oztop N., Cakmak R., Soyer O. M., Ormeci A., et al.
63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 9 - 13 Kasım 2012, cilt.56, (Özet Bildiri)
2012
201246. Response to tenofovir treatment of treatment-naive and adefovir experienced patients with chronic hepatitis b
KESKİN O., Ormeci A., Kabacam G., Akyuz F., Aniktar H., Karaca C., et al.
63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 9 - 13 Kasım 2012, cilt.56, (Özet Bildiri)
2012
201247. Investigation of resistance mutations in the HBV DNA samples that isolated from patients with chronic Hepatitis nucleoside/nucleotide analogues by INNO-LIPA HBV DR and ultradeep pyrosequencing methods
MEŞE S., ARIKAN M., ÇAKİRİS A., ABACI N., ÖNEL D., USTEK D., et al.
2nd World Congress on Virology, Las Vegas, Amerika Birleşik Devletleri, 20 - 22 Ağustos 2012, cilt.4, sa.4, ss.147, (Tam Metin Bildiri)
2012
201248. Success of Two Different Endoscopic Submucosal Resection Methods in Gastric Subepithelial Lesions
Karaca C., Soyer O. M., Akyuz F., Baran B., Ormeci A., Gokturk S., et al.
Digestive Disease Week (DDW), California, Amerika Birleşik Devletleri, 19 - 22 Mayıs 2012, cilt.75, ss.136, (Özet Bildiri)
2011
201149. ANTIVIRAL RESISTANCE IN NAIVE GENOTYPE D CHRONIC HEPATITIS B PATIENTS BY ULTRA-DEEP PYROSEQUENCING
Akyuz F., Ciftci S., Keskin F., Pinarbasi B., Baran B., Ustek D., et al.
62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 4 - 08 Kasım 2011, cilt.54, (Özet Bildiri)
2010
201050. A NATIONWIDE PREVALENCE STUDY AND RISK FACTORS FOR HEPATITIS A, B, C AND D INFECTIONS IN TURKEY
Tozun N., ÖZDOĞAN O. C., Cakaloglu Y., İDİLMAN R., Karasu Z., AKARCA U. S., et al.
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 29 Ekim - 02 Kasım 2010, cilt.52, (Özet Bildiri)
2010
201051. CLEVUDINE TREATMENT OF CHRONIC DELTA HEPATITIS
Yakut M., Seven G., Baran B., Kabacam G., Karatayli E., BOZDAYI A. M., et al.
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 29 Ekim - 02 Kasım 2010, cilt.52, (Özet Bildiri)
2009
200952. CLONAL ANALYSIS OF THE QUASISPECIES OF ANTIVIRAL RESISTANT HBV GENOMES IN PATIENTS WITH ENTECAVIR RESISTANCE TREATED WITH RESCUE LAMIVUDINE-ADEFOVIR COMBINATION THERAPY
Karatayli E., İDİLMAN R., Karatayli S. C., Cevik E., AKARCA U. S., Kaymakoglu S., et al.
60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 30 Ekim - 03 Kasım 2009, cilt.50, (Özet Bildiri)
2008
200853. Ultra-Deep Pyrosekans (UDPS) yöntemi ile naiv kronik B hepatitli hastalarda antiviral direnç araştırılması.
AKYÜZ F., ÇİFTÇİ S., KESKİN F., PINARBASI B., ÇAKIRİS A., ABACI N., et al.
26. Ulusal Gastroenteroloji Haftası, Ankara, Türkiye, 14 - 18 Ekim 2008, ss.206, (Özet Bildiri)
2007
200754. A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease
Poturoglu S., KAYMAKOĞLU S., polat N. G., Ibrisim D., Ahishali E., AKYÜZ F., et al.
Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 Mayıs 2007, cilt.132, (Özet Bildiri)
2006
200655. Entecavir maintained virologic suppression through 3 years of treatment in antiviral-naive HBeAg(+) patients (ETV 022/901)
Chang T., Chao Y., Kaymakoglu S., Cheinquer H., Pessoa M., Gish R., et al.
57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 27 - 31 Ekim 2006, cilt.44, (Özet Bildiri)
2005
200556. A multicenter, randomized, prospective study of 14 days ranitidine bismuth citrate vs. lansoprazole based triple therapies for the eradication of Helicobacter pylori in dyspeptic patients.
Avsar E., KAYMAKOĞLU S., Erzin Y., Poturoglu S., Dincer D., Tiftikci A., et al.
Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Illinois, Amerika Birleşik Devletleri, 14 - 19 Mayıs 2005, cilt.128
2003
200357. Combined or monotherapy, which is better in AntiHBe (+) chronic hepatitis B ?
Danalioglu A., KAYMAKOĞLU S., Cakaloglu Y., DEMİR K., AKYÜZ F., Aksoy N., et al.
Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 Mayıs 2003, cilt.124, (Özet Bildiri)
1999
199958. Hepatopulmonary Syndrome In Noncirrhotic Portal Hypertensive Patients
Kaymakoğlu S., Kahraman T., Kudat H.
The 34th Annual Meeting Of The European Association For The Study Of The Liver. Naples, Italy. , Naples, İtalya, 8 - 12 Nisan 1999, cilt.30, ss.2-23, (Özet Bildiri)
Desteklenen Projeler
2010 - 2011
2010 - 2011
Kronik hepatit B`de tedaviye yanıtsızlığın belirlenmesinde virusa ait genetik değişikliklerin rolü
Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi
KAYMAKOĞLU S. (Yürütücü)